A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist.
作者信息
Salas Rachel E, Allen Richard P, Earley Christopher J, Gamaldo Charlene E
出版信息
Sleep. 2009 May;32(5):587-8. doi: 10.1093/sleep/32.5.587.
Abstract
摘要
相似文献
1
A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist.
Sleep. 2009 May;32(5):587-8. doi: 10.1093/sleep/32.5.587.
2
Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
J Neurol Sci. 2010 Mar 15;290(1-2):52-6. doi: 10.1016/j.jns.2009.11.010. Epub 2009 Dec 6.
3
Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
Sleep. 2013 Oct 1;36(10):1501-7. doi: 10.5665/sleep.3044.
4
Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
Psychosomatics. 2010 May-Jun;51(3):271-3. doi: 10.1176/appi.psy.51.3.271.
5
Pathological gambling plus hypersexuality in restless legs syndrome: a new case.
Neurol Sci. 2011 Aug;32(4):707-9. doi: 10.1007/s10072-011-0605-5. Epub 2011 May 13.
6
Pramipexole (Mirapex) for restless legs syndrome.
Med Lett Drugs Ther. 2007 Mar 26;49(1257):26-8.
7
Dopamine agonist induced compulsive eating behaviour in a Parkinson's disease patient.
Pharm World Sci. 2010 Apr;32(2):114-6. doi: 10.1007/s11096-009-9358-0. Epub 2009 Dec 29.
8
Pramipexole: new indication. Restless legs: still no satisfactory drug treatment.
Prescrire Int. 2007 Feb;16(87):12.
9
Treatment of Pramipexole-Induced Problematic Sexual Behaviors.
Prim Care Companion CNS Disord. 2021 Feb 18;23(1):20br02663. doi: 10.4088/PCC.20br02663.
10
Successful discontinuation of oxycodone under pramipexole treatment for restless legs syndrome due to withdrawal.
Psychiatry Clin Neurosci. 2021 Mar;75(3):112-113. doi: 10.1111/pcn.13184. Epub 2020 Dec 22.
引用本文的文献
1
Amelioration of obsessive-compulsive disorder by intracellular acidification of cortical neurons with a proton pump inhibitor.
Transl Psychiatry. 2024 Jan 16;14(1):27. doi: 10.1038/s41398-024-02731-3.
2
Sleep-related movement disorders.
Neurol Sci. 2012 Jun;33(3):491-513. doi: 10.1007/s10072-011-0905-9. Epub 2011 Dec 28.
3
Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety.
Behav Pharmacol. 2011 Oct;22(7):711-3. doi: 10.1097/FBP.0b013e32834afebe.
4
Update in restless legs syndrome.
Curr Opin Neurol. 2010 Aug;23(4):401-6. doi: 10.1097/WCO.0b013e32833bcdd8.
本文引用的文献
1
Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
J Clin Neurosci. 2007 Dec;14(12):1178-81. doi: 10.1016/j.jocn.2007.01.009. Epub 2007 Aug 27.
2
Predictors of impulsivity and reward seeking behavior with dopamine agonists.
Parkinsonism Relat Disord. 2008;14(1):28-32. doi: 10.1016/j.parkreldis.2007.05.006. Epub 2007 Aug 16.
3
Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
Sleep Med. 2007 Aug;8(5):520-30. doi: 10.1016/j.sleep.2007.03.022. Epub 2007 Jun 1.
4
Pathological gambling associated with dopamine agonist use in restless legs syndrome.
Parkinsonism Relat Disord. 2007 Dec;13(8):535-6. doi: 10.1016/j.parkreldis.2006.10.001. Epub 2007 Jan 30.
5
Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists.
Neurology. 2007 Jan 23;68(4):301-3. doi: 10.1212/01.wnl.0000252368.25106.b6.
6
Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.
Mov Disord. 2007 Mar 15;22(4):590-1. doi: 10.1002/mds.21303.
7
Symptoms of attention-deficit/hyperactivity disorder in adults with restless legs syndrome.
Sleep. 2004 Dec 15;27(8):1499-504. doi: 10.1093/sleep/27.8.1499.
8
Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine.
Sleep. 1999 Nov 1;22(7):961-8. doi: 10.1093/sleep/22.7.961.
Zotero 插件